This double-edge effect of DOT1L, in promoting leukemia and antagonizing reprogramming harmonizes with the view of cancer transformation as an incomplete reprogramming event in a post-stem cell that maintains some phenotypic traits of its developmental stage of origin. Here, DOT1L is linked to leukemia.